table of contents

Personalized Medicine in the Aftermath of COVID-19

Quick takes: Q&A with Jeff Evelhoch on Imaging Biomarkers for Alzheimer’s Disease

Something to Smile About: The Journey Toward a Cure with Rare Disease Foundation NFED

The Center for Applied Genomics at The Children’s Hospital of Philadelphia – Pediatric Perspectives on Genomic Medicine

How Harvard Business School is Accelerating Precision Medicine

Quick takes: Q&A with Steve Anderson on bringing biomarkers from development to market

The Data-Powered Patient: Precision Medicine Enabled by Decentralized Identity and Blockchain

NC Creates Foundational Precision Health Initiative, Sara Imhof, Senior Director, Precision Health

North Carolina: a Global Life Science Leader, Sara Imhof, Senior Director, Precision Health

Best Practices for NGS-Based Cancer Diagnostics

Personalization and standardization: Can we have it all? What other industries can teach healthcare

Activating Patients: The Path to Personalizing Cancer Treatment

Quick takes: Q&A with Marielena Mata on International Activities in Precision Medicine, Biomarkers, and Companion Diagnostics

The Licensing Conundrum: How Licensing Can Facilitate (or Impede) Access to Research Models

The business of science

Majors, Organizational Legitimacy and Rents from Blockbuster Innovation in the Biopharma Industry

 

TFS

 Tweets

  • Precision MedicineNew post: Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling ,
  • Precision MedicineAccess to care remains a barrier to patients and caregivers across the globe. Join us November 17 as we introduce n… ,
  • Precision MedicinePrecision Medicine News November 12, 2020 - ,
×